Evidence map›Paper›PMID 29643204›Full record

ArticleGenome research2018

L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis.

Stephanie N Schauer, Patricia E Carreira, Ruchi Shukla, Daniel J Gerhardt, Patricia Gerdes, Francisco J Sanchez-Luque, Paola Nicoli, Michaela Kindlova, Serena Ghisletti, Alexandre Dos Santos and 6 more

Open access · greenAbstract read
In one paragraph

Article in Genome research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Transposons disrupt genomic stability and trigger cancers.Frontiers in cellular and infection microbiology · 2025
    Review
  12. Article
  13. Regulation and function of transposable elements in cancer genomes.Cellular and molecular life sciences : CMLS · 2024
    Review
  14. Article
  15. Article
  16. DNA methylation markers in the detection of hepatocellular carcinoma.European journal of cancer (Oxford, England : 1990) · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 6 countries.

Stephanie N Schauer *Mater Research Institute-University of Queensland, Woolloongabba, QLD 4102, Australia.
Patricia E Carreira *Mater Research Institute-University of Queensland, Woolloongabba, QLD 4102, Australia.
Ruchi Shukla *Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE1 7RU, United Kingdom.
Daniel J GerhardtMater Research Institute-University of Queensland, Woolloongabba, QLD 4102, Australia.
Patricia GerdesMater Research Institute-University of Queensland, Woolloongabba, QLD 4102, Australia.
Francisco J Sanchez-LuqueMater Research Institute-University of Queensland, Woolloongabba, QLD 4102, Australia.
Paola NicoliDepartment of Experimental Oncology, European Institute of Oncology, 20146 Milan, Italy.
Michaela KindlovaMater Research Institute-University of Queensland, Woolloongabba, QLD 4102, Australia.
Serena GhislettiHumanitas Clinical and Research Center, 20089 Milan, Italy.
Alexandre Dos SantosINSERM, U1193, Paul-Brousse University Hospital, Hepatobiliary Centre, Villejuif 94800, France.
Delphine RapoudINSERM, U1193, Paul-Brousse University Hospital, Hepatobiliary Centre, Villejuif 94800, France.
Didier SamuelINSERM, U1193, Paul-Brousse University Hospital, Hepatobiliary Centre, Villejuif 94800, France.
Jamila FaivreINSERM, U1193, Paul-Brousse University Hospital, Hepatobiliary Centre, Villejuif 94800, France.
Adam D EwingMater Research Institute-University of Queensland, Woolloongabba, QLD 4102, Australia.
Sandra R RichardsonMater Research Institute-University of Queensland, Woolloongabba, QLD 4102, Australia.
Geoffrey J FaulknerMater Research Institute-University of Queensland, Woolloongabba, QLD 4102, Australia.
University of Queensland · AUMater Research · AUInserm · FREuropean Institute of Oncology · ITHôpital Paul-Brousse · FRHumanitas University · ITNewcastle University · GBUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The retrotransposon Long Interspersed Element 1 (LINE-1 or L1) is a continuing source of germline and somatic mutagenesis in mammals. Deregulated L1 activity is a hallmark of cancer, and L1 mutagenesis has been described in numerous human malignancies. We previously employed retrotransposon capture sequencing (RC-seq) to analyze hepatocellular carcinoma (HCC) samples from patients infected with hepatitis B or hepatitis C virus and identified L1 variants responsible for activating oncogenic pathways. Here, we have applied RC-seq and whole-genome sequencing (WGS) to an

Indexed as

AdultAgedAged, 80 and overAnimalsATP-Binding Cassette Sub-Family B Member 4ATP Binding Cassette Transporter, Subfamily BCarcinoma, HepatocellularCell Transformation, NeoplasticFemaleHumansLiverLiver NeoplasmsLong Interspersed Nucleotide ElementsMaleMammalsMice, KnockoutATP-Binding Cassette Sub-Family B Member 4ATP Binding Cassette Transporter, Subfamily BRetroelements

Identifiers

PMID29643204
PMCPMC5932605
OpenAlexW2801902861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.